West Pharmaceutical Services reported $267.4M in EBITDA for its fiscal quarter ending in September of 2026.





Ebitda Change Date
Align Technology USD 232.86M 3.72M Jun/2026
Baxter International USD 474M 165M Jun/2026
Becton, Dickinson and Co. USD 1.71B 1B Jun/2026
Charles River Laboratories USD 298.04M 25.1M Sep/2026
Cooper Companies USD 67.9M 255.5M Mar/2026
Dentsply International USD 146M 44M Sep/2026
Haemonetics USD 111.41M 15.25M Sep/2026
ICU Medical USD 113.91M 3.88M Sep/2026
Insulet USD 233.7M 33.9M Sep/2026
Integra LifeSciences USD 79.79M 1.37M Sep/2026
IQVIA Holdings USD 1.03B 38M Sep/2026
J&J USD 8.99B 721M Jun/2026
Medtronic USD 2.63B 174M Jun/2026
Merit Medical Systems USD 103.93M 461K Sep/2026
Neogen USD 41.6M 3.8M Jun/2026
OraSure Technologies USD -17.7M 4.06M Dec/2025
Quidel USD 148M 18.7M Sep/2026
Repligen USD 43.84M 70K Sep/2026
Solventum Corp USD 523M 147M Sep/2026
STAAR Surgical USD 14.36M 5.64M Sep/2026
Terumo JPY 8.62B 108.05B Sep/2026
West Pharmaceutical Services USD 267.4M 23.8M Sep/2026